Filter News
Area of Research
- (-) Isotopes (7)
- (-) Materials (46)
- Advanced Manufacturing (1)
- Biology and Environment (18)
- Clean Energy (43)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (3)
- Isotope Development and Production (1)
- Materials for Computing (6)
- National Security (12)
- Neutron Science (44)
- Nuclear Science and Technology (4)
- Quantum information Science (1)
- Supercomputing (39)
News Topics
- (-) Climate Change (5)
- (-) Cybersecurity (3)
- (-) Energy Storage (19)
- (-) Frontier (2)
- (-) High-Performance Computing (2)
- (-) Isotopes (10)
- (-) Neutron Science (18)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (1)
- Artificial Intelligence (4)
- Bioenergy (8)
- Biology (4)
- Biomedical (4)
- Buildings (2)
- Chemical Sciences (20)
- Composites (3)
- Computer Science (9)
- Coronavirus (2)
- Critical Materials (8)
- Decarbonization (4)
- Environment (7)
- Exascale Computing (1)
- Fusion (2)
- Grid (2)
- ITER (1)
- Machine Learning (2)
- Materials (38)
- Materials Science (36)
- Microscopy (12)
- Molten Salt (2)
- Nanotechnology (21)
- National Security (3)
- Net Zero (1)
- Nuclear Energy (3)
- Partnerships (8)
- Physics (14)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (10)
- Renewable Energy (1)
- Security (2)
- Summit (1)
- Sustainable Energy (7)
- Transformational Challenge Reactor (1)
- Transportation (4)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
For more than 50 years, scientists have debated what turns particular oxide insulators, in which electrons barely move, into metals, in which electrons flow freely.